Corren Jonathan
Allergy Research Foundation, Los Angeles, California 90025, USA.
Curr Opin Pulm Med. 2007 Jan;13(1):13-8. doi: 10.1097/MCP.0b013e328010d0db.
The relationship between allergic rhinitis and asthma has intrigued practicing physicians since the turn of the century. Investigations during the past two decades have led to an increased understanding of this relationship.
A growing body of evidence clearly demonstrates that patients with allergic rhinitis, in the absence of asthma, have distinct abnormalities of lower airway function, including alterations in physiology, histology and biochemistry. In addition, epidemiologic surveys have consistently shown allergic rhinitis as an independent risk factor for developing asthma, and that preexisting abnormalities in lung function may predispose to lower airway disease development. Clinical trials show that specific allergen immunotherapy for children and adults with seasonal allergic rhinitis reduces the risk of developing asthma. In patients with established asthma and concomitant allergic rhinitis, several medications have significant effects upon the upper and lower airways, including intranasal corticosteroids, oral antihistamines, and leukotriene receptor antagonists.
Our understanding of the natural history of allergic rhinitis could lead to improvements in early intervention, potentially preventing the progression of allergic rhinitis to asthma. Aggressive treatment of rhinitis in patients with concomitant asthma may enhance asthma outcomes and quality of life for all patients with these chronic diseases.
自世纪之交以来,过敏性鼻炎与哮喘之间的关系一直吸引着执业医师。过去二十年的研究增进了我们对这种关系的理解。
越来越多的证据清楚地表明,没有哮喘的过敏性鼻炎患者存在下呼吸道功能的明显异常,包括生理、组织学和生物化学方面的改变。此外,流行病学调查一致显示过敏性鼻炎是发生哮喘的独立危险因素,并且肺功能预先存在的异常可能易导致下呼吸道疾病的发生。临床试验表明,针对患有季节性过敏性鼻炎的儿童和成人进行特异性变应原免疫治疗可降低患哮喘的风险。在已确诊哮喘且伴有过敏性鼻炎的患者中,几种药物对上、下呼吸道均有显著作用,包括鼻用糖皮质激素、口服抗组胺药和白三烯受体拮抗剂。
我们对过敏性鼻炎自然病程的理解可能会带来早期干预的改善,有可能预防过敏性鼻炎发展为哮喘。对伴有哮喘的患者积极治疗鼻炎可能会改善哮喘的治疗效果,并提高所有患有这些慢性病患者的生活质量。